Back to the main directory
Press Release
- European Commission Approves Pfizer’s ABRYSVO™ to Help Protect Infants through Maternal Immunization and Older Adults from RSV by BusinessWire
- ESI Group : Déclaration mensuelle du nombre total d'actions et de droits de vote au 31 juillet 2023 by BusinessWire
- ORPEA : Information relative au nombre total de droits de vote et d’actions composant le capital social by BusinessWire
- BUREAU VERITAS - Nombre d'actions et droits de vote au 31 Juillet 2023 by GlobeNewsWire
- Immobilière Dassault : Mise à disposition du rapport financier semestriel 2023 by BusinessWire
- ABL Diagnostics : Assemblée Générale Ordinaire et Extraordinaire du jeudi 14 septembre 2023 – Modalités de mise à disposition ou de consultation des documents préparatoires by BusinessWire
- Mortgage Rates Continue to Surge by GlobeNewsWire
- COMMUNIQUE DE PRESSE: NACON : DES ANNONCES ET DES NOUVEAUTÉS À DÉCOUVRIR À LA GAMESCOM 2023 by GlobeNewsWire
- Toll Brothers Announces Opening of Regency at Babcock Ranch Exclusive Active-Adult 55+ Community in Punta Gorda, Florida by GlobeNewsWire
- Income Financial Trust Financial Results to June 30, 2023 by GlobeNewsWire
- Fuller, Smith & Turner PLC: Transaction in Own Shares by EQS Group AG
- Holding(s) in Company by EQS Group AG
- CORRECTING and REPLACING CI Global Asset Management Announces August 2023 Distributions for the CI ETFs by BusinessWire
- Nokia Corporation: Repurchase of own shares on 24.08.2023 by GlobeNewsWire
- Toll Brothers Announces New Luxury Townhome Community Coming Soon to Malvern, Pennsylvania by GlobeNewsWire
- The North West Company Inc. Second Quarter Results and Conference Call by GlobeNewsWire
- EQS-News: CARLSON INVESTMENTS SE und HPI AG prüfen strategischen Aktientausch durch Absichtserklärung by EQS Group AG
- SIG IVÆRKSÆTTER TILBAGEKØB AF EGNE AKTIER by GlobeNewsWire
- REV Group to Release Third Quarter 2023 Earnings on Wednesday, September 13, 2023 by BusinessWire
- NXP Semiconductors Announces Quarterly Dividend by GlobeNewsWire
- BridgeBio Pharma to Present Detailed Results from the Phase 3 ATTRibute Study in Patients with Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) at European Society of Cardiology (ESC) Congress 2023 by GlobeNewsWire
- Credit Acceptance Announces Completion of $400.0 Million Asset-Backed Financing by GlobeNewsWire
- Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders by GlobeNewsWire
- Robex Resources Inc. präsentiert am Dienstag, 29. August 2023, die Ergebnisse des zweiten Quartals 2023 by GlobeNewsWire
- Concrete Pumping Holdings Sets Third Quarter 2023 Earnings Conference Call for Thursday, September 7, 2023 by GlobeNewsWire